🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

4,589 results for “Pharma” Clear

  1. [14C]-LX4211

    LEXICON PHARMACEUTICALS, INC.

    Healthy

    phase 1 small molecule completed

    1 trial

  2. [14C]-Larotinib

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Healthy Adult Male Volunteers

    phase 1 small molecule completed

    1 trial

  3. [14C]-NV-5138

    SUPERNUS PHARMACEUTICALS, INC.

    Healthy Volunteers

    phase 1 small molecule completed

    2 trials

  4. [14C]-PC14586

    PMV Pharmaceuticals

    Healthy Male Volunteers

    phase 1 small molecule completed

    1 trial

  5. [14C]-rencofilstat 225mg

    Hepion Pharmaceuticals

    NASH With Fibrosis

    phase 1 small molecule completed

    1 trial

  6. [14C]Clifutinib

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Healthy Adult Male

    phase 1 small molecule completed

    1 trial

  7. [14C]SSS17

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Healthy Subjects (HS)

    phase 1 small molecule active

    1 trial

  8. a 60 mg dose of the hydrocodone bitartrate extended-release tablet administered as either two 30-mg tablets (Treatment A) or one 60-mg tablet (Treatment B).

    Teva Pharma GmbH

    Pain

    phase 1 small molecule completed

    1 trial

  9. amilo-5MER

    Galmed Pharmaceuticals

    Inflammatory Disease

    phase 1 small molecule completed

    1 trial

  10. amoxicillin-clavulanic acid

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  11. anle138b (TEV-56286)

    Teva Pharma GmbH

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  12. anti-EGFR monoclonal antibody

    Dragonboat Biopharmaceutical Company Limited

    Healthy Volunteers

    phase 1 small molecule active

    1 trial

  13. autologous ET1402L1-CART cells

    AEON Biopharma

    Hepatocellular Carcinoma

    phase 1 mab terminated

    1 trial

  14. bendamustine

    Teva Pharma GmbH

    Malignancy

    phase 1 small molecule completed

    1 trial

  15. brontictuzumab

    Mereo BioPharma Group plc

    Metastatic Colorectal Cancer

    phase 1 small molecule completed

    1 trial

  16. cannabis

    BRIGHT MINDS BIOSCIENCES INC.

    Behavioral Pharmacology of Cannabis

    phase 1 small molecule completed

    1 trial

  17. cefprozil

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    1 trial

  18. conivaptan hydrochloride

    CUMBERLAND PHARMACEUTICALS INC

    Liver Disease

    phase 1 small molecule completed

    2 trials

  19. conivaptan hydrochloride

    CUMBERLAND PHARMACEUTICALS INC

    Kidney Diseases

    phase 1 small molecule completed

    1 trial

  20. dMAb AZD5396

    INOVIO PHARMACEUTICALS, INC.

    Healthy Volunteers

    phase 1 other completed

    1 trial

  21. entinostat

    Syndax Pharmaceuticals

    Lung Cancer

    phase 1 small molecule completed

    1 trial

  22. firibastat

    Quantum Biopharma

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  23. hGH-ViaDerm™ System (hGH or somatropin)

    Teva Pharma GmbH

    Growth Hormone Deficiency

    phase 1 small molecule completed

    1 trial

  24. iloperidone (oral tablet)

    Vanda Pharmaceuticals Netherlands B.V.

    Safety and Tolerability of Iloperidone

    phase 1 small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources